Extending the Human Lifespan, a BioWorld special report, examines the companies developing “Fountain of Youth” drugs. In this episode, the writers discuss this scientific holy grail.

Download transcript

Executives from Amylyx Pharmaceuticals Inc. and Clene Inc., along with a key Penn State ALS expert, discuss what the future of medicine holds for patients.

Download transcript

BioWorld Senior Analyst Karen Carey explores the newest data and where it is leading.

Download transcript

Infection control expert William Schaffner of the Vanderbilt University School of Medicine joins to discuss the CDC’s Advisory Committee on Immunization Practices and how COVID-19 put the committee’s schedule into overdrive.

Download transcript

BioWorld Senior Science Editor Anette Breindl goes in depth about how long COVID-19 emerged and is being defined.

Download transcript

Guests Ryan Abbott, a professor of law and medicine, as well as the leader of the Artificial Inventor Project, and Jim Belfiore, senior vice president of innovation at Clarivate plc, have a discussion about the brave new world AI is creating.

Download transcript

Insights into the controversial drug come from guests Michael Agadjanyan, president of Nuravax Inc., which is developing antibodies for preventing Alzheimer’s and Parkinson’s diseases, along with Robert Glanzman, chief medical officer of Clene Nanomedicine Inc.

Download transcript